MoneyWorks4Me

The September 2023 quarter revenue stood at Rs. 21460.00 millions, up 11.31% as compared to Rs. 19280.00 millions during the corresponding quarter last year.Net profit stood at Rs. 3270.00  millions  compared to Rs. 2720.00 millions in the corresponding previous quarter,high by 20.22%.Operating Profit saw a handsome growth to 7510.00 millions from 6310.00 millions in the quarter ended September 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 21460.00 19280.00 11.31 42670.00 38610.00 10.52 76950.00 67420.00 14.14
Other Income 150.00 110.00 36.36 260.00 400.00 -35.00 820.00 2040.00 -59.80
PBIDT 7510.00 6310.00 19.02 14990.00 13250.00 13.13 25470.00 23040.00 10.55
Interest 770.00 620.00 24.19 1670.00 1130.00 47.79 2980.00 2360.00 26.27
PBDT 6740.00 5690.00 18.45 13320.00 12120.00 9.90 22490.00 20680.00 8.75
Depreciation 1920.00 1560.00 23.08 3750.00 3050.00 22.95 6720.00 6020.00 11.63
PBT 4820.00 4130.00 16.71 9570.00 9070.00 5.51 15770.00 14660.00 7.57
TAX 1550.00 1410.00 9.93 3070.00 3080.00 -0.32 5250.00 4750.00 10.53
Deferred Tax 720.00 710.00 1.41 1420.00 1520.00 -6.58 2510.00 2220.00 13.06
PAT 3270.00 2720.00 20.22 6500.00 5990.00 8.51 10520.00 9910.00 6.16
Equity 1692.30 1692.30 0.00 1692.30 1692.30 0.00 1692.30 846.20 99.99
PBIDTM(%) 35.00 32.73 6.93 35.13 34.32 2.37 33.10 34.17 -3.14
Peers
Company Name CMP
Sun Pharma. Inds. 1756.90
Dr. Reddys Labs. 1195.10
Cipla 1303.30
Lupin 1960.00
Zydus Lifesciences 1115.10
View more..